24-LUN-139-BNT (BNT327-01): A Phase II, Multi-site, Open-label, Parallel Group Trial of BNT327 in Combination with Chemotherapy for Participants with Untreated Extensive-Stage Small-Cell Lung Cancer and Participants with Previously Treated Small-Cell Lung